SEC Form 4 · accession 0001127602-19-008762
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Mahon
Officer — EVP & General Counsel
Period of report
Feb 27, 2019
Accepted (ET)
Feb 27, 2019 · 5:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F2 | $111.00 | Feb 27, 2019 | A | 61,094 | A | Mar 15, 2019 | Mar 15, 2028 | Common Stock | 61,094 | 61,094 | D |
Explanation of responses
- F1These performance-based stock options were initially awarded on March 15, 2018, subject to a one-year performance condition tied to company-wide milestone performance for 2018, which was determined on February 27, 2019. Number of stock options reported represents the number of options earned based on milestone performance.
- F2These stock options vest in one-third increments on each of March 15, 2019, 2020 and 2021.